4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001544227-21-000013
Options or other derivatives
- Executive Chair acquired 24,000 shares (grant or award)
From the SEC's structured data for this filing
Tempest Therapeutics, Inc. Filed Acc 0001544227-21-000013
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…